✦ LIBER ✦

Impaired Responsiveness to the Platelet P2Y12 Receptor Antagonist Clopidogrel in Patients With Type 2 Diabetes and Coronary Artery Disease

✍ Scribed by Angiolillo, Dominick J.; Jakubowski, Joseph A.; Ferreiro, José Luis; Tello-Montoliu, Antonio; Rollini, Fabiana; Franchi, Francesco; Ueno, Masafumi; Darlington, Andrew; Desai, Bhaloo; Moser, Brian A.; Sugidachi, Atsuhiro; Guzman, Luis A.; Bass, Theodore A.

Book ID: 126245383
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 969 KB
Volume: 64
Category: Article
ISSN: 1558-3597
DOI: 10.1016/j.jacc.2014.06.1170

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lack of association between the P2Y12 re

Lack of association between the P2Y12 receptor gene polymorphism and platelet response to clopidogrel in patients with coronary artery disease

✍ Dominick J. Angiolillo; Antonio Fernandez-Ortiz; Esther Bernardo; Celia Ramírez; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 103 KB

Reduced platelet response to aspirin in

Reduced platelet response to aspirin in patients with coronary artery disease and type 2 diabetes mellitus

✍ S.B. Mortensen; S.B. Larsen; E.L. Grove; S.D. Kristensen; A.-M. Hvas 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 262 KB

Clopidogrel resistance in North Indian p

Clopidogrel resistance in North Indian patients of coronary artery disease and lack of its association with platelet ADP receptors P2Y1 and P2Y12 gene polymorphisms

✍ Kar, Rakhee; Meena, Arvind; Yadav, Birendra K.; Yadav, Rakesh; Kar, Sitanshu Sek 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 485 KB

Impact of P2Y12-ADP receptor polymorphis

Impact of P2Y12-ADP receptor polymorphism on the efficacy of clopidogrel dose-adjustment according to platelet reactivity monitoring in coronary artery disease patients

✍ Laurent Bonello; Nathalie Bonello-Palot; Sébastien Armero; Caroline Bonello; Oma 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 166 KB

Inhibition of Platelet Aggregation by AZ

Inhibition of Platelet Aggregation by AZD6140, A Reversible Oral P2Y12 Receptor Antagonist, Compared With Clopidogrel in Patients With Acute Coronary Syndromes

✍ Robert F. Storey; Steen Husted; Robert A. Harrington; Stanley Heptinstall; Rober 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 797 KB

Bleeding risk with AZD6140, a reversible

Bleeding risk with AZD6140, a reversible P2Y12 receptor antagonist, vs. clopidogrel in patients undergoing coronary artery bypass grafting in the DISPERSE2 trial

✍ S. Husted; R. A. Harrington; C. P. Cannon; R. F. Storey; P. Mitchell; H. Emanuel 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB